Israel’s oral COVID vaccine gets greenlight for trial in South Africa – The Jerusalem Post

The Oravax Medical vaccine is based on Oramed’s “POD” oral delivery technology and Premas’s vaccine technology. Oramed’s technology can be used to orally administer a number of protein-based therapies, which would otherwise be delivered by injection. Premas has been working on developing a vaccine against the novel coronavirus since March. Source: Israel’s oral COVID vaccine gets greenlight for trial in South Africa – The Jerusalem Post